IASO BioMed Announces Addition of Four Members to Its Scientific Advisory Board
13 nov. 2018 09h00 HE
|
IASO BioMed, Inc.
Company developing a Next Generation Treatment for Low Testosterone CENTENNIAL, Colo., Nov. 13, 2018 (GLOBE NEWSWIRE) -- IASO BioMed, Inc. (“IASO” or the “Company”), an innovative biotechnology...